Original article (1997) updated by: Ardalan Akbari, Medical Student, Faculty of Medicine, University of British Columbia, Vancouver, Canada. DermNet Editor in Chief: Adjunct Assoc. Prof. Amanda Oakley, Dermatologist, Hamilton, New Zealand. October 2019.
Erythema nodosum is a type of panniculitis, an inflammatory disorder affecting subcutaneous fat. It presents as tender red nodules on the anterior shins. Less commonly, they affect the thighs and forearms [1–3].
Erythema nodosum can occur in all ethnicities, sexes, and ages, but is most common in women between the ages of 25 and 40 [4]. It is 3–6 times more common in women than in men except before puberty when the incidence is the same in both sexes [5].
What are the causes of erythema nodosum?
Erythema nodosum is a hypersensitivity reaction of unknown cause in up to 55% of patients [6]. In other cases, it is associated with an identified infection, drug, inflammatory condition, or malignancy [7].
Throat infections (streptococcal disease or viral infection)
What are the clinical features of erythema nodosum?
Erythema nodosum presents with tender bilateral erythematous subcutaneous nodules 3–20 cm in diameter erupting over one to several weeks. They are accompanied by fever and joint pain. In 50% the ankle is swollen and painful for up to several weeks. The knees and other joints can also be affected [8].
Common clinical findings [9-12]
The nodules are found on the anterior lower legs, knees and arms and rarely on the face and neck.
They are ill-defined, warm, oval, round or arciform, and without ulceration
The nodules are initially bright to deep red.
They spontaneously resolve within eight weeks, through aviolaceous, brownish, or yellowish/green bruise-like appearance known as erythema contusiformis.
Erythema nodosum does not cause permanent scarring.
What are the complications of erythema nodosum?
Erythema nodosum has few known complications and lesions usually resolve spontaneously. A rare complication is encapsulated fat necrosis, or ‘mobile encapsulated lipoma’ [14].
How is erythema nodosum diagnosed?
Erythema nodosum is primarily a clinical diagnosis confirmed by laboratory tests and histopathology [8]. The pathology of erythema nodosum shows inflammation primarily of the septa between the subcutaneous fat lobules without vasculitis [15].
Supporting investigations [4,7]
Appropriate tests may include:
Complete blood count with differential, C-reactive protein levels (infectious and inflammatory causes)
Chest X-ray (tuberculosis and sarcoidosis)
Throat swab and anti-streptolysin O and streptodornase serology (streptococcal infection)
Viral serology (preferably two samples at four-week intervals)
Stool culture and evaluation for ova and parasites in patients with gastrointestinal symptoms
What is the differential diagnosis for erythema nodosum?
A range of causes of panniculitis should be considered in a patient with subcutaneous nodules, especially if lesions are not located on the legs, there is ulceration, or symptoms last longer than eight weeks.
Panniculitis can be predominantly septal (inflammation between lobules) or lobular (inflammatory cells within subcutaneous fat lobules) [16]. Mixed septal and lobular inflammation can occur.
Nodules due to predominantly septal panniculitis include:
Medium vessel vasculitis, for example, due to polyarteritis nodosa in which there are tender subcutaneous nodules associated with ulceration, necrosis, livedo racemosa, fever, joint pain, myalgia, and peripheralneuropathy
Pancreatic panniculitis in which subcutaneous nodules may become ulcerated or fluctuant. Laboratory tests reveal elevated lipase, amylase and trypsin levels
Systemic corticosteroids (1 mg/kg daily until resolution of erythema nodosum) may be prescribed if infection, sepsis, and malignancy have been ruled out [9,11].
Oral potassium iodide as a supersaturated solution (400–900 mg/day) may be prescribed for one month if available [17].
What is the outcome for erythema nodosum?
Erythema nodosum follows a relatively benign and favourable course. It is important to recognise the underlying cause, if any, and initiate symptomatic treatment [4]. Most cases resolve within days to weeks. Relapses may occur in approximately one-third of cases erythema nodosum may become a chronic or persistent disorder lasting for 6 months and occasionally for years [13].
References
Cox NH, Jorizzo JL, Bourke JF, Savage COS. Vasculitis, neutrophilic dermatoses and related disorders. In: Rook’s Textbook of Dermatology. 8th edn. Burns T, Breathnach S, Cox N, Griffiths C (eds). Wiley-Blackwell, Hoboken 2010: Vol 3, 50.1.